Trial intelligence / Profile preview

Pulsatile vs Continuous Oxytocin for Myometrial Desensitization

NCT02338089Completed

Sponsor
Mount Sinai Hospital
Start
Jan 2015
Primary completion
Jun 2015
Modality
Peptides
Countries
1
01

Overview

Randomised, open-label trial of oxytocin in postpartum hemorrhage (PPH) (3 arms), sponsored by Mount Sinai Hospital. Primary endpoint: Motility Index at 8 hours. Started Jan 2015; status: completed.

02

Drugs

oxytocin
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on NCT02338089.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02338089.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call